E weputara "Ntuziaka maka ịgbanye insulin na-enweghị agịga maka ndị ọrịa mamịrị" na China, bụ nke gosipụtara ntinye ntinye insulin na-enweghị agịga n'usoro ọgwụgwọ ọrịa shuga nke China, ma meekwa China ka ọ bụrụ obodo maka nkwalite teknụzụ ụlọ ọgwụ na-enweghị agịga.
N'otu oge ahụ, a malitere ịkwalite ịgba ọgwụ insulin na-enweghị agịga na mba niile, ma jiri sirinji na-enweghị agịga mee ihe n'ime ngalaba narị ụlọ ọgwụ dị na China, na-aghọ ngwaọrụ mbụ na-enweghị agịga na-anabata dị ka ngwá ọrụ ọgwụgwọ.
Dị ka a na-eduga Enterprise n'ọhịa nke agịga-free injection na China, na-aga n'ihu ọhụrụ ọhụrụ nke "TECHiJET" jet technology aghọtala kenha nlereanya imewe nke "TECHiJET" agịga-free injection mmiri usoro ihe dị iche iche ọgwụ, na kpọmkwem akara nke injection omimi na mgbasa ebe. , iji kwado ọgwụ ahụ iji nweta mmalite kachasị mma. Ya mere, sirinji na-enweghị TECHiJETneedle abụghị naanị ngwa mmeghe dị mfe, kamakwa usoro ọgwụgwọ nnyefe ọgwụ.
Tupu etinye ya n'ụlọọgwụ ahụ, "TECHIJET" emeela ọnụ ọgụgụ dị ukwuu nke ụlọ ọgwụ res earch experiments.
The "Pharmacokine ics na Pharmacodyna mics Study of Humalog enweghị agịga injection" rụrụ site Prọfesọ ma ọ bụ Li Qifu nke First Mgbakwunye H ospital nke Chongqing Medical University na 2015 kwenye med na atụnyere agịga na-free yringe nke "TECHiJET" na-enweghị insulin agịga na-free-insulin. usoro mmepụta insulin physiological;
Na 2016, ọmụmụ "Tụnyere mmetụta s nke agịga -fr ee injecting ion na omenala insu lin pen on bloo d sugar control na insulin etoju na ndị ọrịa na T 2DM" nkwonkwo ly rụrụ site Prọfesọ Xiao Xinhua nke Peking Union Medical College H osp ital na Prọfesọ Guo Lix na nke Beijing Hospital kwenye med: "Quwit chọrọ injection."
postprandia l njikwa shuga dị n'ọbara ka mma, na mgbanwe shuga ọbara postprandial dị obere;
Malite na 2018, ọ dịruo afọ 2 wee bụrụ onye Profess ma ọ bụ Ji Linong sitere na ụlọ ọgwụ Peop le's na Beijing wee jiri nkwonkwo malite ọmụmụ P Hase III na ụlọ ọgwụ iri kacha elu. Ọmụmụ ihe "FREE" na-eji "T ECHIJET" agịga-fr ee yringe bụ ugbu a t ọ kachasị n'ụwa. The res erch us ing the gold egosi nke ọbara su gar control "glycat ed hemoglobin" dị ka isi irè obs er vation index, n'okpuru th er es erch nke C hina si top endocrinology ọkachamara otu, kwadoro uru nke "TECHiJET" agịga-free technology res earch na ịzụlite ment innovation nke China na ụlọ ọgwụ na-adịghị egosipụta ike na ụlọ ọgwụ na ụlọ ọgwụ China. l res earch na agịga igba ion t echnology. Ọmụmụ ihe "FREE" gosipụtara nkwubi okwu ndị a:
E jiri ya tụnyere insulin H na agịga h, mgbanwe site na isi mmalite nke HbA1c na-enweghị agịga abụghị ihe na-emetụta insulin p en Group, ma nwee ọnụ ọgụgụ dị elu karịa na ụlọ ọgwụ. Ebe ịgba ogwu dị ala, ọ dịghịkwa induration emepụtara; Needle-fr ee ịgbanye ion nke insu lin na-ebute obere mgbu na afọ ojuju dị elu nke onye ọrịa, nke nwere ike ime ka onye ọrịa dịkwuo mma." TECHIJET" ga-aga n'ihu na-abụ onye na-eduzi agịga n'ụwa - fr ee teknụzụ injection dị ka isi iji baara ndị ọrịa uru ma mee ka nlekọta ahụike dị mma. Ọ bụ r espons ibility a na ezigbo nke "T ECHIJET" iji kwalite e na nkà mmụta sayensị na nkà na ụzụ ọganihu nke mba ọgwụ aku na uba, na ọhụụ nke "agịga-free diagnos bụ na-emeso ment, na-eme ka ụwa a mma ebe" ga-n'ezie ga-enweta ozugbo o kwere omume.
Oge nzipu: Ọktoba 13-2022